Y. Charoenvit

发表

CEL-1000--a peptide with adjuvant activity for Th1 immune responses.

K. Rosenthal, Y. Charoenvit, N. Goel, 2004, Vaccine.

A Small Peptide (CEL-1000) Derived from the β-Chain of the Human Major Histocompatibility Complex Class II Molecule Induces Complete Protection against Malaria in an Antigen-Independent Manner

Denise L. Doolan, Daniel J. Carucci, D. Carucci, 2004, Antimicrobial Agents and Chemotherapy.

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers.

J. Maguire, D. Doolan, P. Hobart, 2000, Vaccine.

Induction in Humans of CD8+ and CD4+ T Cell and Antibody Responses by Sequential Immunization with Malaria DNA and Recombinant Protein1

S. Hoffman, D. Carucci, P. de la Vega, 2004, The Journal of Immunology.

Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A.

S. Hoffman, D. Carucci, Joe D. Cohen, 2004, Vaccine.

Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

S. Hoffman, D. Doolan, P. Hobart, 1996, The Journal of experimental medicine.

A Role for Apical Membrane Antigen 1 during Invasion of Hepatocytes by Plasmodium falciparum Sporozoites*

Markus S. Mueller, A. Thomas, M. Blackman, 2004, Journal of Biological Chemistry.

Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites.

S. Hoffman, L. Yuan, M. Sedegah, 1990, Bulletin of the World Health Organization.

Immunization with hybrid hepatitis B virus core particles carrying circumsporozoite antigen epitopes protects mice against Plasmodium yoelii challenge.

R. Wirtz, Y. Charoenvit, F. Schödel, 1997, Behring Institute Mitteilungen.

Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.

S. Hoffman, P. de la Vega, E. Franke, 1996, Journal of immunology.

Production of monoclonal antibodies against a 19-kD recombinant Plasmodium vivax MSP1 for detection of P. vivax malaria in Turkey.

S. Hoffman, M. Türk, Y. Charoenvit, 2004, Hybridoma and Hybridomics.

Protective efficacy against malaria of a combination sporozoite and erythrocytic stage vaccine.

S. Hoffman, T. Daly, C. Long, 1996, Immunology letters.

Recombinant Protein Immunization with Malaria DNA and Cell and Antibody Responses by Sequential T + and CD4 + Induction in Humans of CD8

Patricia De la Vega, S. Hoffman, D. Carucci, 2004 .

Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular/intradermal routes.

S. Hoffman, E. Gorak, Sanjai Kumar, 2002, Human gene therapy.

Pan DR binding sequence provides T-cell help for induction of protective antibodies against Plasmodium yoelii sporozoites.

S. Hoffman, A. Sette, E. Appella, 1999, Vaccine.

Plasmid Vaccine Expressing Granulocyte-Macrophage Colony-Stimulating Factor Attracts Infiltrates Including Immature Dendritic Cells into Injected Muscles1

S. Hoffman, Sanjai Kumar, M. Sedegah, 2000, The Journal of Immunology.

Cells into Injected Muscles Infiltrates Including Immature Dendritic Colony-Stimulating Factor Attracts Granulocyte-Macrophage Plasmid Vaccine Expressing

S. Hoffman, Sanjai Kumar, M. Sedegah, 2000 .

Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity

S. Hoffman, D. Carucci, D. Freilich, 2016, Malaria Journal.

Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization

D. Carucci, M. Galinski, D. Kaslow, 2007, Malaria Journal.

Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF

J. Sacci, J. Aguiar, M. Sedegah, 2004, Genes and Immunity.

Persistence of Protective Immunity to Malaria Induced by DNA Priming and Poxvirus Boosting: Characterization of Effector and Memory CD8+-T-Cell Populations

S. Hoffman, D. Carucci, D. Doolan, 2002, Infection and Immunity.

In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines.

S. Hoffman, M. Gardner, J. Sacci, 1998, International journal of molecular medicine.

Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody.

S. Hoffman, P. de la Vega, M. Sedegah, 1995, Experimental parasitology.

Malaria sporozoite penetration. A new approach by double staining.

L. Rénia, J. Verhave, T. Ponnudurai, 1988, Journal of immunological methods.

Simultaneous Induction of Multiple Antigen-Specific Cytotoxic T Lymphocytes in Nonhuman Primates by Immunization with a Mixture of Four Plasmodium falciparum DNA Plasmids

S. Hoffman, M. Gardner, J. Sacci, 1998, Infection and Immunity.

The development of a multivalent DNA vaccine for malaria

S. Hoffman, M. Gardner, J. Sacci, 2004, Springer Seminars in Immunopathology.

Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein.

S. Hoffman, Sanjai Kumar, S. Khusmith, 1991, Science.

Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites.

S. Hoffman, L. Yuan, M. Sedegah, 1991, Journal of immunology.

Antigens cross reactive with Plasmodium falciparum merozoite surface protein 4 are found in pre-erythrocytic and sexual stages.

J. Menting, J. Sacci, R. Coppel, 2000, Molecular and biochemical parasitology.

Improving Protective Immunity Induced by DNA-Based Immunization: Priming with Antigen and GM-CSF-Encoding Plasmid DNA and Boosting with Antigen-Expressing Recombinant Poxvirus1 2

S. Hoffman, J. Sacci, P. Hobart, 2000, The Journal of Immunology.

Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.

S. Hoffman, R. Hunter, C. Alving, 1995, Journal of immunology.

Boosting of DNA Vaccine-Elicited Gamma Interferon Responses in Humans by Exposure to Malaria Parasites

S. Hoffman, D. Freilich, T. Richie, 2005, Infection and Immunity.

Developmental changes in the circumsporozoite proteins ofPlasmodium berghei andP. gallinaceum in their mosquito vectors

A. Krettli, N. Boulanger, Y. Charoenvit, 2004, Parasitology Research.

Sequence of the immunodominant epitope for the surface protein on sporozoites of Plasmodium vivax.

S. Hoffman, T. McCutchan, W. Maloy, 1985, Science.

Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development.

T. Burkot, R. Wirtz, K. Esser, 1987, Bulletin of the World Health Organization.

Experimental sporotrichosis in Syrian hamsters

R. Taylor, Y. Charoenvit, 1979, Infection and immunity.

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

S. Hoffman, D. Doolan, P. Hobart, 1998, Science.

Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro.

D. Mazier, Y. Charoenvit, C. Paul, 1986, Science.

Dual action of anti-sporozoite antibodies in vitro.

L. Rénia, L. Yuan, D. Mazier, 1989, Journal of immunology.

Evidence for diversity of Plasmodium falciparum sporozoite surface antigens derived from analysis of antibodies elicited in humans

C. Desgranges, K. Brahimi, Y. Charoenvit, 1990, Infection and immunity.

Malaria Epitopes Expressed on the surface of Recombinant Tobacco Mosaic Virus

S. Hoffman, Y. Charoenvit, S. Reinl, 1995, Bio/Technology.

Induction of CD4+ T cell-dependent CD8+ type 1 responses in humans by a malaria DNA vaccine

S. Hoffman, D. Carucci, D. Doolan, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes

Patricia De la Vega, S. Hoffman, S. Hoffman, 1997, Infection and immunity.

Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys.

S. Hoffman, A. Krieg, H. Davis, 1999, Vaccine.

Novel Antigen Identification Method for Discovery of Protective Malaria Antigens by Rapid Testing of DNA Vaccines Encoding Exons from the Parasite Genome

J. Carlton, D. Carucci, Joshua A Russell, 2004, Infection and Immunity.

Identification and Characterization of the Protective Hepatocyte Erythrocyte Protein 17 kDa Gene of Plasmodium yoelii, homolog of Plasmodium falciparum Exported Protein 1*

S. Hoffman, P. de la Vega, D. Doolan, 1996, The Journal of Biological Chemistry.

Assessment of age-dependent immunity to malaria in transmigrants.

Purnomo, S. Hoffman, M. Bangs, 1997, The American journal of tropical medicine and hygiene.

Localization of CS and non-CS antigens in the sporogonic stages of Plasmodium yoelii.

C. Atkinson, L. Beaudoin, M. Sedegah, 1990, Bulletin of the World Health Organization.

Evaluation of monoclonal antibodies against Plasmodium vivax sporozoites for ELISA development

T. Burkot, R. Wirtz, K. Esser, 1991, Medical and veterinary entomology.

Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA

S. Hoffman, D. Freilich, J. Aguiar, 2012, Human vaccines & immunotherapeutics.

A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP142 in a Prime/Boost Heterologous Immunization Regimen Partially Protects Aotus Monkeys against Blood-Stage Challenge

D. Tang, D. Doolan, T. Richie, 2017, Clinical and Vaccine Immunology.

Plasmodium berghei: cloning of the circumsporozoite protein gene.

J. Weber, R. Wirtz, W. Maloy, 1987, Experimental parasitology.

Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens

L. Yuan, M. Sedegah, Y. Charoenvit, 1987, Infection and immunity.

Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus.

S. Hoffman, Y. Charoenvit, S. Reinl, 1995, Bio/technology.

CD4+ T-Cell- and Gamma Interferon-Dependent Protection against Murine Malaria by Immunization with Linear Synthetic Peptides from a Plasmodium yoelii17-Kilodalton Hepatocyte Erythrocyte Protein

S. Hoffman, J. Sacci, D. Doolan, 1999, Infection and Immunity.

Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants.

S. Hoffman, R. Hunter, J. Sacci, 1998, Vaccine.

Plasmodium falciparum. Mechanisms of innate and acquired protection against Plasmodium falciparum in Javanese transmigrant adults and children newly resident in malaria-endemic Northwest Papua.

Sanjai Kumar, T. Richie, D. Fryauff, 2003, Advances in experimental medicine and biology.

Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence.

S. Hoffman, J. Broderson, L. Yuan, 1991, Science.

Seroprevalence of antibodies to repetitive domains of Plasmodium vivax circumsporozoite protein in United Arab Emirates children.

Khaled M. A. Amiri, M. Lukic, Y. Charoenvit, 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device.

S. Hoffman, S. Hoffman, J. Sacci, 2001, Vaccine.

Killer Whale Predation on Sea Otters Linking Oceanic and Nearshore Ecosystems

Denise L. Doolan, D. Doolan, P. Hobart, 1998 .

Reduced immunogenicity of DNA vaccine plasmids in mixtures

D. Carucci, W. Rogers, Sanjai Kumar, 2004, Gene Therapy.

Evaluation of vaccines designed to induce protective cellular immunity against the Plasmodium yoelii circumsporozoite protein: vaccinia, pseudorabies, and Salmonella transformed with circumsporozoite gene.

S. Hoffman, M. Sedegah, M. Cochran, 1990, Bulletin of the World Health Organization.

Malaria DNA vaccines in Aotus monkeys.

D. Doolan, P. Hobart, M. Sedegah, 1997, Vaccine.

A monoclonal antibody directed against the sporozoite stage of Plasmodium vivax binds to liver parenchymal cells.

S. Hoffman, K. Nakamura, C. Chizzolini, 1992, Immunology letters.

Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites

S. Hoffman, M. Sedegah, Y. Charoenvit, 1993, Infection and immunity.

Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii. A rodent model for examining antimalarial sporozoite vaccines.

T. McCutchan, J. Welsh, W. Maloy, 1987, The Journal of biological chemistry.

Antigenic analysis of Plasmodium yoelii liver stages by fluorescence antibody assays.

M. Sedegah, Y. Charoenvit, P. Druilhe, 1991, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

Killer whale predation on sea otters linking oceanic and nearshore ecosystems

Tinker, M. Sedegah, Y. Charoenvit, 1998, Science.

Humoral immune responses against Plasmodium vivax MSP1 in humans living in a malaria endemic area in Flores, Indonesia.

S. Hoffman, D. Kaslow, Y. Charoenvit, 1998, The Southeast Asian journal of tropical medicine and public health.

Cloning of Plasmodium yoelii genes expressing three different sporozoite-specific antigens.

P. Rogers, M. Sedegah, Y. Charoenvit, 1989, Microbial Pathogenesis.

A malaria sporozoite surface antigen distinct from the circumsporozoite protein.

S. Hoffman, J. Campbell, M. Sedegah, 1990, Bulletin of the World Health Organization.

Suppression of parasite antigen-specific lymphoid blastogenesis in African trypanosomiasis.

Y. Charoenvit, S. Tokuda, G. Campbell, 1981, Journal of immunology.